NCT02968810 2026-03-18
Simvastatin in Preventing Liver Cancer in Patients With Liver Cirrhosis
National Cancer Institute (NCI)
Phase 2 Active not recruiting
Clinical Trials
16 trialsNCT07392541 2026-02-06
Adebrelimab Combined With Gemcitabine, Cisplatin, and Simvastatin for Advanced Biliary Tract Cancer
Tongji Hospital
Phase 1/2 Recruiting
NCT03654053 2026-01-07
SACRED
VA Office of Research and Development
Phase 3 Active not recruiting
NCT03889795 2025-10-20
Phase IB Metformin, Digoxin, Simvastatin in Solid Tumors
University of Toledo
Phase 1 Active not recruiting
NCT07003815 2025-06-04
Envafolimab With Chemotherapy and Simvastatin in Advanced Biliary Tract Cancer
Tongji Hospital
Phase 2 Not yet recruiting
NCT06030622 2024-04-19
C3
State University of New York - Downstate Medical Center
Phase 1/2 Recruiting
NCT02390843 2020-04-03
AflacST1402
Emory University
Phase 1 Completed
NCT02161822 2020-03-25
Capecitabine Plus Simvastatin in Locally Advanced Rectal Cancer Patients
Samsung Medical Center
Phase 2 Unknown
NCT03086291 2019-12-30
A Phase I Study of High Dose Simvastatin in Patients With Gastrointestinal Tract Cancer Who Failed to Standard Chemotherapy
Samsung Medical Center
Phase 1 Unknown
NCT02026583 2018-01-17
A Single Arm, Phase II Study of Simvastatin Plus XELOX and Bevacizumab as First-line Chemotherapy in Metastatic Colorectal Cancer Patients
Samsung Medical Center
Phase 2 Completed
NCT00944463 2017-02-17
Trial of Simvastatin and Gemcitabine in Pancreatic Cancer Patients
Samsung Medical Center
Phase 2 Completed
NCT01099085 2017-02-17
Trial of XP (Capecitabine/CDDP) Simvastatin in Advanced Gastric Cancer Patients
Samsung Medical Center
Phase 3 Completed
NCT01110785 2013-09-17
Simvastatin and Panitumumab in Treating Patients With Advanced or Metastatic Colorectal Cancer
National Cancer Institute (NCI)
Phase 2 Unknown
NCT01190462 2013-08-12
Cetuximab and Simvastatin in Treating Patients With Advanced or Metastatic Colorectal Cancer
National Cancer Institute (NCI)
Phase 2 Unknown
NCT01238094 2013-06-14
Trial of XELIRI/FOLFIRI + Simvastatin Followed by Simvastatin Maintenance in Metastatic Colorectal Cancer
Samsung Medical Center
Phase 3 Unknown
NCT00313859 2012-02-02
Phase II Study of Simvastatin Plus Irinotecan, Fluorouracil, and Leucovorin(FOLFIRI) for Metastatic CRC
Samsung Medical Center
Phase 2 Completed